BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brown EE, Sturm AC, Cuchel M, Braun LT, Duell PB, Underberg JA, Jacobson TA, Hegele RA. Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association. Journal of Clinical Lipidology 2020;14:398-413. [DOI: 10.1016/j.jacl.2020.04.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Block RC, Bang M, Peterson A, Wong ND, Karalis DG. Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) - Results of a US national survey. J Clin Lipidol 2021;15:682-9. [PMID: 34593357 DOI: 10.1016/j.jacl.2021.09.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Cabot E, Duell PB, Purnell JQ, Osborn D, Craigan C, Pamir N, Fazio S. Use of commercial genetic testing to help reclassify LDL receptor variants in clinical practice: A case report. J Clin Lipidol 2021;15:447-50. [PMID: 33992589 DOI: 10.1016/j.jacl.2021.04.007] [Reference Citation Analysis]
3 Chowns J, Hoffman-andrews L, Marzolf A, Reza N, Owens AT. Cardiovascular Genetics. Medical Clinics of North America 2022. [DOI: 10.1016/j.mcna.2021.11.007] [Reference Citation Analysis]
4 Mszar R, Webb GB, Kulkarni VT, Ahmad Z, Soffer D. Genetic Lipid Disorders Associated with Atherosclerotic Cardiovascular Disease. Medical Clinics of North America 2022. [DOI: 10.1016/j.mcna.2021.11.009] [Reference Citation Analysis]
5 Simha V. Management of hypertriglyceridemia. BMJ. [DOI: 10.1136/bmj.m3109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
6 Warden BA, Duell PB. Evinacumab for treatment of familial hypercholesterolemia. Expert Rev Cardiovasc Ther 2021;19:739-51. [PMID: 34253139 DOI: 10.1080/14779072.2021.1955349] [Reference Citation Analysis]
7 Sturm AC, Truty R, Callis TE, Aguilar S, Esplin ED, Garcia S, Haverfield EV, Morales A, Nussbaum RL, Rojahn S, Vatta M, Rader DJ. Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis. JAMA Cardiol 2021;6:902-9. [PMID: 34037665 DOI: 10.1001/jamacardio.2021.1301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jacob E, Hegele RA. Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences? Curr Atheroscler Rep 2022. [PMID: 35386091 DOI: 10.1007/s11883-022-01018-6] [Reference Citation Analysis]
9 Lazarte J, Hegele RA. Editorial comment: hazards of interpreting genetic reports. Curr Opin Lipidol 2021;32:81-2. [PMID: 33606402 DOI: 10.1097/MOL.0000000000000738] [Reference Citation Analysis]
10 Arrobas Velilla T, Brea Á, Valdivielso P; los investigadores del Proyecto ARIAN., Investigadores del proyecto ARA. Implantation of a biochemical and genetic screening programme for family hypercholesterolaemia. Collaboration between the clinical laboratory and lipid units: Design of the ARIAN Project. Clin Investig Arterioscler 2021:S0214-9168(21)00073-5. [PMID: 34090714 DOI: 10.1016/j.arteri.2021.03.004] [Reference Citation Analysis]
11 Kaya Z, Sal E, Yorulmaz A, Hsieh YP, Gülen H, Yıldırım AT, Niu DM, Tekin A. Genetic basis and hematologic manifestations of sitosterolemia in a group of Turkish patients. J Clin Lipidol 2021:S1933-2874(21)00115-X. [PMID: 34304999 DOI: 10.1016/j.jacl.2021.07.001] [Reference Citation Analysis]
12 Ashraf AP, Sunil B, Bamba V, Breidbart E, Brar PC, Chung S, Gupta A, Khokhar A, Kumar S, Lightbourne M, Kamboj MK, Miller RS, Patni N, Raman V, Shah AS, Wilson DP, Kohn B. Case Studies in Pediatric Lipid Disorders and Their Management. J Clin Endocrinol Metab 2021:dgab568. [PMID: 34363474 DOI: 10.1210/clinem/dgab568] [Reference Citation Analysis]
13 Kiage J, Venkatanarayan A, Roth M, Elam M. Atorvastatin-associated rhabdomyolysis in a patient with a novel variant of the SLCO1B1 gene: A case report. J Clin Lipidol 2021:S1933-2874(21)00287-7. [PMID: 34887219 DOI: 10.1016/j.jacl.2021.11.007] [Reference Citation Analysis]
14 Sunil B, Ashraf AP. Childhood Hypertriglyceridemia: Is It Time for a New Approach? Curr Atheroscler Rep 2022. [PMID: 35107763 DOI: 10.1007/s11883-022-01000-2] [Reference Citation Analysis]
15 Brown EE. The genetic counselor's role in management of patients with dyslipidemia. Curr Opin Lipidol 2021;32:83-8. [PMID: 33492006 DOI: 10.1097/MOL.0000000000000732] [Reference Citation Analysis]
16 Cahua-Pablo JÁ, Gómez-Zamudio JH, Reséndiz-Abarca CA, Tello-Flores VA, Eulogio-Metodio Y, Ramírez-Vargas MA, Cruz M, Del Carmen Alarcón-Romero L, Matia-García I, Marino-Ortega LA, Zubillaga-Guerrero MI, Flores-Alfaro E. Genetic variants in SLC22A1 are related to serum lipid levels in Mexican women. Lipids 2021. [PMID: 34927264 DOI: 10.1002/lipd.12334] [Reference Citation Analysis]
17 Bays HE, Kulkarni A, German C, Satish P, Iluyomade A, Dudum R, Thakkar A, Rifai MA, Mehta A, Thobani A, Al-saiegh Y, Nelson AJ, Sheth S, Toth PP. Ten Things to Know About Ten Cardiovascular Disease Risk Factors – 2022. American Journal of Preventive Cardiology 2022. [DOI: 10.1016/j.ajpc.2022.100342] [Reference Citation Analysis]
18 Peterson AL, McNeal CJ, Wilson DP. Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia. Curr Atheroscler Rep 2021;23:64. [PMID: 34453222 DOI: 10.1007/s11883-021-00959-8] [Reference Citation Analysis]
19 Landstrom AP, Kim JJ, Gelb BD, Helm BM, Kannankeril PJ, Semsarian C, Sturm AC, Tristani-Firouzi M, Ware SM; American Heart Association Council on Genomic and Precision Medicine; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Lifestyle and Cardiometabolic Health. Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association. Circ Genom Precis Med 2021;14:e000086. [PMID: 34412507 DOI: 10.1161/HCG.0000000000000086] [Reference Citation Analysis]
20 Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbuś K, Gąsior M, Jankowski P, Jóźwiak J, Kłosiewicz-Latoszek L, Kowalska I, Małecki M, Prejbisz A, Rakowski M, Rysz J, Solnica B, Sitkiewicz D, Sygitowicz G, Sypniewska G, Tomasik T, Windak A, Zozulińska-Ziółkiewicz D, Cybulska B. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021. Arch Med Sci 2021;17:1447-547. [PMID: 34900032 DOI: 10.5114/aoms/141941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang C, Xu B, Wang P, Yu W, Zeng X, Xiong N, Yin P, Liu Q, Lin H. Association of dyslipidemia with chronic non-malignant pain in elderly patients with femoral neck fractures treated by primary total hip arthroplasty: a retrospective study. J Int Med Res 2021;49:3000605211045224. [PMID: 34590917 DOI: 10.1177/03000605211045224] [Reference Citation Analysis]
22 Trinder M, Brunham LR. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance. Curr Opin Lipidol 2021;32:103-11. [PMID: 33395106 DOI: 10.1097/MOL.0000000000000737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Lui DTW, Lee ACH, Tan KCB. Management of Familial Hypercholesterolemia: Current Status and Future Perspectives. J Endocr Soc 2021;5:bvaa122. [PMID: 33928199 DOI: 10.1210/jendso/bvaa122] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol 2021;5:100149. [PMID: 34327491 DOI: 10.1016/j.ajpc.2021.100149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Hernandez P, Passi N, Modarressi T, Kulkarni V, Soni M, Burke F, Bajaj A, Soffer D. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis. Curr Atheroscler Rep 2021;23:72. [PMID: 34515873 DOI: 10.1007/s11883-021-00962-z] [Reference Citation Analysis]